Bengaluru, January 30, 2016: Polyetheretherketone (PEEK) suture anchors and Softfix-PK interference screws manufactured by BIOTEK, an Indian manufacturer of arthroscopy implants, have received the CE mark certificate and Indian FDA approval. All these next generation arthroscopy implants are made from Evonik’s VESTAKEEP ® PEEK.
PEEK suture anchors are ideal for soft tissue repair in shoulder, hip, elbow, ankle, wrist & knee arthroscopic procedures. They have tremendous pull-out strength and excellent biocompatibility. Implant can be manually inserted using the disposable handled version.
Softfix-PK has a special design and is the first interference screw to feature perforations. Depending on the screw size, the screw body can have 6 to 10 perforations. Reduced Implant mass, increased bone-implant interface, three-dimensional bone ingrowth or faster bone substitution are only some of the advantages of Softfix-PK screw made from the VESTAKEEP® PEEK.
Excellent mechanical properties with VESTAKEEP® PEEK
With Evonik’s cooperation, BIOTEK could add radiolucent and biocompatible PEEK products to its existing range of titanium products. “We have chosen VESTAKEEP® PEEK because it is known for its excellent mechanical properties but also its superior biocompatibility and biostability. With this material we can achieve the expected features of our new generation products” says Rajendra Patel, Managing Director BIOTEK.
“We are pleased with the approval of PEEK arthroscopy implants which are made of VESTAKEEP®,” said Dharmesh Chotalia, Associate Director-Business Development at Evonik India. Theexcellent sterilization resistance and good combination of stiffness and ductility of VESTAKEEP® PEEK make it suitable for medical implant applications that must meet the extremely high demands/requirements of the medical industry. VESTAKEEP® PEEK provides a modulus of elasticity similar to that of bone.
Corporate Comm India(CCI NewsWire)
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…